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Abstract 
Natural products isolated from plant sources are well known for their 
pharmacological potential in diversity of disease treatments such as inflammatory 
or cancer conditions. Mango (Mangifera indica L.) and Juglans regia are thought 
to be rich of functional phytochemicals. To clarify the anticancer activity, aqueous 
extracts of Juglans regia (JR) nut and Mangifera indica L (MI) fruit were 
exanimated on chronic lymphocytic leukemia (CLL) B lymphocytes and their 
mitochondria and the results were compared with those of normal B lymphocytes. 
Cellular parameters such as viability and caspase 3 activity, and mitochondrial 
parameters such as reactive oxygen species (ROS), mitochondria membrane 
potential (MMP), mitochondrial swelling, and cytochrome c release were 
evaluated. Our results demonstrated that the extract of Mangifera indica L 
increased cytotoxicity and caspase 3 activation through mitochondria pathway only 
in CLL B lymphocytes and also the extract of Juglans regia did not show 
cytotoxicity and caspase 3 activation on CLL and healthy B lymphocytes. Our in-
vitro findings on isolated mitochondria indicated that mitochondrial ROS 
formation, MMP collapse, and mitochondrial swelling and cytochrome c release 
were significantly (p < 0.05) increased after addition of Mangifera indica only in 
cancerous mitochondria. These results demonstrated that Mangifera indica can act 
as a promising source for anti-cancer drug candidates by directly and selectively 
targeting mitochondria and inducing selective mitochondria mediated apoptosis on 
CLL B lymphocytes.   
Keywords: Mangifera indica, Juglans regia, Chronic Lymphocytic Leukemia, 
Mitochondria, Cytotoxicity, Anticancer activity. 
 
 
 
 
 
 
Introduction 
Chronic lymphocytic leukemia (CLL) is characterized by accumulation of 
malignant B CD5
+
 cells, which are resistant to apoptosis (1). Despite standard 
treatments and more recent targeted therapies,(2) CLL is still incurable. Given that 
in CLL, multiple pathways are dysregulated (3) and considering that targeting one 
single pathway is often not sufficient to delete tumor cells, it is therefore necessary 
to develop novel strategies able to activate multiple apoptotic pathways and, 
simultaneously inhibit dysregulated survival pathways (4). Studies demonstrated 
that CLL cells contain significantly more mitochondria than normal lymphocytes. 
Moreover, the studies demonstrated that mitochondrial content may have 
therapeutic implications. Also, today mitochondria as main organelles in the cell 
have good promising targets for treatment of the cancers (5). For many years, 
medicinal plants have been used to treat different diseases. The plants and their 
extracts are therapeutically superior to their single isolated constituents (6). They 
are generally plentiful, low cost, and relatively nontoxic in clinical practice (6). 
There are types of herbs, fruits, and their compounds acting as an inhibitor of 
carcinogen formation, blockers of carcinogen interaction, and suppressor of tumor 
progression (7).  
Mangifera indica (MI) has been an important herb in the medical systems for 4000 
years. It is one of the most popular of all tropical fruits (8). Ripe mango fruit is 
considered to be invigorating and freshening. The juice is restorative tonic and 
used in heat stroke (8). Mangiferin, being a polyphenolic antioxidant and a 
glucosyl xanthone, has strong antioxidant, anti-lipid peroxidation, 
immunomodulation, cardiotonic, hypotensive, wound healing, anti-degenerative, 
and antidiabetic activities (9). Gallotannins are also phenolics in mango which 
have shown anti-cancer activity (10). Juglans Regia (J. Regia) belongs to the 
family Juglandaceae commonly known as walnut tree. J. Regia extract contains 
ellagitannins containing anti-cancer agent and having anti-inflammatory properties 
(11). The key chemical composition of walnut is juglone (5 hydroxy-1, 4-
naphthoquinone),  the  toxic  compound  which  is found  only in  green  and  fresh  
walnuts,  but  such property disappears in dried leaves (12). Other several phenolic 
compounds with antioxidant properties have been identified in J. Regia leaves 
(13). Walnut leaves are considered a source of healthcare compounds, and have 
been extensively used in traditional medicine for treatment of skin inflammations, 
hyperhidrosis, and ulcers and for its anti-diarrheal, anti-helmintic, antiseptic, and 
astringent properties (14). Several studies suggest that regular consumption of nuts, 
mostly walnuts, may have beneficial effects against oxidative stress mediated 
diseases such as cardiovascular disease and cancer (15). 
The objective of the present study was to evaluate the in-vitro cytotoxicity of the 
aqueous extract of Mangifera indica and Juglans as a routine fruit and nut 
consumed in many countries against human chronic lymphocytic leukemia cells. 
We also compared the obtained results of the extracts with those of normal B 
lymphocytes and mitochondria. 
Experimental 
Preparation and standardization of extracts  
The aqueous extracts Juglans Regia and Mangifera Indica were prepared and 
standardized according to our published work (16).  
Patients 
Fifteen CLL patients entered this study. Diagnoses of CLL were performed 
according to the National Cancer Institute- sponsored Working Group guidelines, 
and clinical staging was based on the Binet classification. Age-matched controls 
were obtained from fifteen healthy donors. This study was approved by the Shahid 
Beheshti University of Medical Sciences research ethics committee and all the 
patients and healthy donors signed an informed consent form (17). 
CLL and Normal B-lymphocytes isolation 
Peripheral blood samples were obtained from CLL patients and healthy donors.  
Mononuclear cells were isolated from blood and tissue samples by utilizing Ficoll-
Paque (GE Healthcare, Waukesha, WI) density gradient centrifugation. After 1 h 
of incubation at 37 C in 5% CO2, adhesive mononuclear cells were removed. 
Those non-adherent lymphocytes were thoroughly washed with the Hank's 
solution. T lymphocytes were removed using anti-CD3 dynabeads. The 
purification of B lymphocytes was assessed by flow cytometry with anti-CD19 
antibodies with FACS. This cell preparation contained about 95% CD19 (B 
lymphocyte antigen) positive cells. It was added stromal cell-derived factor-1 to 
rescue B-lymphocytes from apoptosis (18). 
Cytotoxicity Assay 
B-lymphocytes (1×10
4 
cells/well) were incubated in 96-well plates in the presence 
or absence of extracts for 24 h in a ﬁnal volume of 50 µL. At the end of the 
treatment, 20 µL of MTT (5 mg/mL in PBS) was added to each well and incubated 
for an additional 4 h at 37 ºC. The purple-blue MTT formazan precipitate was 
dissolved in 100 µL of DMSO and the absorbance was measured at 570 nm on 
ELISA reader (19). 
Caspase 3 Activity  
Caspase 3 activity was determined in cell lysate of B-lymphocytes from different 
treatments using “Sigma’s caspase 3 assay kit (CASP- 3-C)”. In brief, this 
colorimetric assay is based on the hydrolysis of substrate peptide, Ac-DEVD-pNA, 
through caspase 3. The released moiety (p-nitroaniline) has a high absorbance at 
405 nm. The concentration of the p-nitroaniline (μM)  released from the  substrate 
is calculated from the absorbance values at 405 nm or from a calibration curve 
prepared with defined p-nitroaniline solutions (20).  
Succinate Dehydrogenases Activity  
The activity of mitochondrial complex II (succinate dehydrogenases or SDH) was 
assayed by measuring the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). Briefly, 100 µL of mitochondrial suspensions 
(1mg protein/mL) was incubated with different concentrations of extracts at 37
 °C 
for 1hour; then, 25 µL of 0.4% of MTT was added to the medium and incubated at 
37
 °C for 30 min. The product of formazan crystals was dissolved in 100 µL 
DMSO and the absorbance at 570 nm was measured with an ELISA reader (Tecan, 
Rainbow hermo, Austria) (18, 21).  
Mitochondrial Swelling assay  
Mitochondria suspensions (at 100 µg protein per well) were incubated in 96-well 
plates at 25 °C in swelling buffer (140 mmol/L KCl, 10 mmol/L NaCl, 2 mmol/L 
MgCl2, 0.5 mmol/L KH2PO4, 20 mmol/L HEPES, 0.5 mmol/L EGTA; adjusted to 
pH 7.2 with KOH) supplemented with 1 mg/mL rotenone and 10 mmol/L 
succinate. Mitochondrial swelling was measured spectrophotometrically in 1-hour 
duration. Mitochondrial swelling results in a decrease in absorbance monitored at 
540 nm (22).  
Mitochondrial ROS formation assay  
Briefly, purified mitochondria were isolated and placed in respiration buffer (0.32 
mM sucrose, 10 mM Tris, 20 mM Mops, 50 μM EGTA, 0.5 mM MgCl2, 0.1 mM 
KH2PO4, and 5 mM sodium succinate). Following this step, DCFH-DA was added 
(final concentration, 10 μM) and then added various concentration of extracts, at 
37 °C for an hour. Then, the fluorescence intensity of DCF was measured using 
Shimadzu RF-5000U fluorescence spectrophotometer at an excitation wavelength 
of 488 nm and emission wavelength of 527 nm (18).  
Mitochondrial MMP Collapse Assay  
Briefly the mitochondrial fractions (1000 µg protein /mL) were incubated with 10 
µM of rhodamine 123 in MMP assay buffer (220 mM sucrose, 68 mM D-mannitol, 
10 mM KCl, 5 mM KH2PO4, 2 mM MgCl2, 50 μM EGTA, 5 mM sodium 
succinate, 10 mM HEPES, and 2 μM Rotenone) and then various concentrations of 
the extracts were added at 37 °C for an hour. The fluorescence was monitored 
using Shimadzu RF-5000U fluorescence spectrophotometer at the excitation and 
emission wavelength of 490 nm and 535 nm, respectively (23).  
Cytochrome c Release Assay   
The concentration of cytochrome c was determined through using the Quantikine 
Human Cytochrome C Immunoassay kit (Minneapolis, Minn). Cytochrome c 
measurement was performed according to the manufacturer’s instructions (18).  
Statistical Analysis 
The results were presented as mean ± SD. The assays were performed in triplicate 
and the mean was used for statistical analysis. Statistical significance was 
determined using the one-way ANOVA test, followed by the post-hoc Tukey test 
when appropriate. Statistical significance was set at p < 0.05 and the parameters of 
mitochondrial dysfunction were analyzed by two-way ANOVA and Bonferonie 
posttest. All graphs were expressed as mean ± SD and  
p < 0.05 was considered statistically significant.  
Results 
 
Viability assay  
Evaluation of the extracts for potential selective toxicity on B lymphocytes cells 
obtained from CLL patients was carried out using the MTT assay. A 500 µg/mL 
concentration of aqueous extract of Mangifera Indica reduced 40% of cancerous B 
lymphocytes viability following 24-hour exposure, while none of the 
concentrations of J. Regia did not show any reduction at cancerous B lymphocytes 
viability at the same time (Figure 1 graph B). Toxicity evaluation in normal 
lymphocytes obtained from healthy donors revealed no significant decrease in cell 
viability after exposure to aqueous extracts J. Regia and Mangifera Indica at 
concentrations of 100-2000 µg/mL (Figure 1 graph A). 
 
Figure 1. Cell viability. Effect of J. Regia and Mangifera Indica aqueous extracts 
on cell viability in normal (A) and cancerous B lymphocytes (B). Cells were 
treated with J. Regia and Mangifera Indica aqueous extracts and cell viability was 
measured by MTT assay following 24-hours of extracts addition.  
Values were expressed as mean ± SD of five separate determinations (n = 5).  
***: Significant difference in comparison with CLL control (p < 0.001). 
ns indicates non-significant with control. 
 
 Caspase 3 assay  
As shown in Figure 2, only Mangifera Indica extract significantly increased the 
activity of apoptosis final mediator, caspae-3 in CLL. To figure out the upstream 
mechanism involved in Mangifera Indica extract induced caspase-3 activation we 
examined the pretreating effect of Z-IETD a caspase 8 inhibitor and cyclosporine 
A (Cs.A), an MPT pore sealing agent and Butylated hydroxytoluene (BHT), a ROS 
scavenger on Mangifera Indica extract treated CLL B-lymphocytes. Our results 
showed that only Cs.A and BHT but not Z-IETD prevented Mangifera Indica 
extract induced caspase 3 activation (p < 0.001) suggesting that Mangifera Indica 
extract activates a ROS-mediated mitochondrial intrinsic pathway in cancerous B-
lymphocytes which could end in apoptosis. 
 
Figure 2. Activity of caspae-3 in normal and CLL B-lymphocytes. CLL and 
healthy B-lymphocytes (10
6
 Cells/mL) were incubated in RPMI 1640 medium in 
conventional condition (37 °C and 5% CO2-air) following the addition of J. Regia 
and Mangifera Indica aqueous extracts to both groups. As shown in Figure 2, 
Mangifera Indica aqueous extract significantly increased the activity of caspae-3 in 
CLL B-lymphocytes BUT NOT healthy B-lymphocytes. However only Cs.A (5 
µM) and BHT (5 µM) but not Z-IETD (10 µM) prevented extract induced caspase 
3 activation.  
Values are expressed as mean ± SD of three separate experiments (n = 5).  
***: Significant difference in comparison with CLL control (p < 0.001). 
###: Significant difference in comparison with Mangifera Indica group (p < 
0.001). ns indicates non-significant with control. 
 
Mitochondrial Assessment  
SDH Activity 
Evaluations of Mangifera Indica and J. Regia extracts for potential activity on 
mitochondria obtained from B-lymphocytes were carried out by studying the 
inhibitory effects of these extracts on SDH activity using the MTT assay. 
Mangifera Indica extract only inhibited succinate dehydrogenase activity in a 
dose-dependent manner in cancerous BUT NOT healthy mitochondria (Figure 3 
graph A and B). 
  
Figure 3. Effect of J. Regia and Mangifera Indica aqueous extracts on succinate 
dehydrogenase activity in both normal (A) and cancerous B lymphocytes 
mitochondria (B). Mitochondria were treated with J. Regia and Mangifera Indica 
aqueous extracts and succinate dehydrogenase activity was measured by MTT 
assay following 1-hour of the extract exposure. Values are mean ± SD of three 
separate experiments.  
Values presented as mean ± SD of five separate experiments (n = 5).  
***: Significant difference in comparison with CLL untreated control (p < 0.001). 
ns indicates non-significant with control. 
 
 
ROS formation  
We examined whether the level of ROS in cancerous and normal mitochondria are 
affected by aqueous extracts J. Regia and Mangifera Indica L.  As shown in Figure 
4, graph B, only Mangifera Indica treatment at 100, 250, and 500 µg/mL 
concentrations for 1 h, significantly induced ROS generation (p < 0.05) in 
cancerous mitochondria. These results suggested that Mangifera Indica induced 
ROS generation might underlie its effect on promoting CLL cell apoptosis. While 
these results showed that J. Regia decreased ROS generation cancerous 
mitochondria. However, as shown in Figure 4 graph A, treatment with both extract 
at 100, 250, and 500 µg/mL concentrations for 1 hour did not induce ROS 
generation in normal mitochondria. 
 
Figure 4. Effect of J. Regia and Mangifera Indica aqueous extracts on ROS 
formation in both normal (A) and cancerous mitochondria (B). Freshly isolated 
purified mitochondria were obtained from both healthy donors and CLL patients 
and then incubated with J. Regia and Mangifera Indica aqueous extracts for 1- 
hour. ROS was measured spectroflourimetrically by DCF staining. ROS formation 
% was enhanced by Mangifera Indica extract in comparison to CLL untreated 
control during 1-hour exposure. 
Values presented as mean ± SD of five separate experiments (n = 5).  
: Significant difference in comparison with CLL untreated control (p < 0.001). 
: Significant difference in comparison with CLL untreated control (p < 0.001). 
ns indicates non-significant with control. 
 
MMP assay  
To search for the mechanisms involved in apoptosis, we examined the effects of J. 
Regia and Mangifera Indica extracts on mitochondrial membrane potential (∆Ψm) 
mitochondria isolated from both groups. Addition of the extracts (100, 250 and 500 
µg/mL) for 1 h showed decreased ∆Ψm in mitochondria obtained from CLL B 
lymphocytes only after exposure to Mangifera Indica extracts (Figure. 5, graph B). 
Addition of the same concentrations of the extracts (100, 250 and 500 µg/mL) on 
normal mitochondria did not show any significant decrease at ∆Ψm for both 
extracts (Figure 5, graph A). 
 Figure 5. Effect of J. Regia and Mangifera Indica aqueous extracts on ∆Ψm 
collapse in normal (A) and cancerous mitochondria (B). Freshly isolated purified 
mitochondria from both healthy and CLL B lymphocytes were treated with 
different concentrations of extracts (100, 250 and 500 µg/mL) for 1-hour. ∆Ψm 
was measured by rhodamine 123 staining with spectrofluorescence method. Our 
data revealed that only Mangifera Indica could induce a significant decrease in 
∆Ψm in cancerous mitochondria but not in normal mitochondria. 
Values presented as mean ± SD of five separate experiments (n = 5).  
: Significant difference in comparison with CLL untreated control (p < 0.001). 
ns indicates non-significant with control. 
 
 
Mitochondrial swelling  
Induction of mitochondrial swelling in isolated lymphocyte mitochondria was 
monitored by following 540 nm absorbance (A540) decrease. Addition Mangifera 
Indica extract (100, 250 and 500 µg/mL) resulted in an extensive mitochondrial 
swelling in cancerous mitochondria obtained from B lymphocytes of CLL patients 
(Figure 6, graph B). Addition of the same concentrations (50 and 100 µg/mL) of 
extract to normal mitochondria did not induce mitochondrial swelling (Figure 5, 
graph A). Addition J. Regia extract (100, 250 and 500 µg/mL) did not result in 
mitochondrial swelling in cancerous and normal mitochondria (Figure 6 A and B).  
  
 
Figure 6. Effect of J. Regia and Mangifera Indica aqueous extracts on 
mitochondrial swelling in normal (A) and cancerous mitochondria (B). Only 
addition of Mangifera Indica aqueous extracts (100, 250 and 500 µg/mL) induced 
mitochondrial swelling in cancerous BUT NOT normal mitochondria. For swelling 
evaluation, absorbance of mitochondrial suspensions at 540 nm were monitored 
every 15 min within 1-hour.  
Values presented as mean ± SD of five separate experiments (n = 5).  
***: Significant difference in comparison with CLL untreated control (p < 0.001). 
ns indicates non-significant with control. 
 
Cytochrome c  
Our results demonstrated that Mangifera Indica extract significantly caused 
mitochondrial swelling and collapse of the mitochondrial membrane potential. 
These events could result in mitochondrial permeability transition and release of 
cytochrome c from mitochondria into the incubation buffer. As shown in Figure 7, 
only Mangifera Indica extract (250 µg/mL) induced significant (p < 0.05) release 
of cytochrome c on the cancerous mitochondria isolated from CLL patients but not 
normal healthy donors. Significantly, the pretreatment of extract -treated 
mitochondria with the MPT inhibitor, cyclosporine A (Cs.A) and ROS scavenger, 
butylated hydroxyl toluene (BHT) prevented cytochrome c release as compared 
with sole Mangifera Indica -treated group (250 µg/mL) (p < 0.05), indicating the 
role of oxidative stress and mitochondrial permeability transition (MPT) pore 
opening in extract induced cytochrome c release. 
 Figure 7. Effect of J. Regia and Mangifera Indica aqueous extracts (250 µg/mL) 
on the cytochrome c release in the lymphocyte mitochondria isolated from CLL 
patients’ group. As shown in this figure, only addition of Mangifera Indica 
aqueous extracts (250 µg/mL) induced cytochrome c release in cancerous BUT 
NOT normal mitochondria, also pretreatment of BHT or Cs.A significantly 
prevented cytochrome c release in the cancerous lymphocyte mitochondria. The 
amount of expelled cytochrome c from mitochondrial fraction into the suspension 
buffer was determined by man Cytochrome c ELISA kit.  
Values presented as mean ± SD of five separate experiments (n = 5).  
***: Significant difference in comparison with CLL untreated control (p < 0.001). 
###: Significant difference in comparison with CLL Mangifera Indica group (p < 
0.001). 
ns indicates non-significant with control 
 
 Discussion 
Cancer is the second leading cause of death worldwide. Natural therapies, such as 
the use of plant-derived products in cancer treatment, may reduce adverse side 
effects during chemotherapy. Recently, a few plant products are being used to treat 
cancer. However, a numerous of many plant products exist that have shown very 
promising anti-cancer properties in-vitro (24). Plants play an important role in 
cancer prevention, as well as in therapy. Medicinal plants provide new active 
chemo-preventive molecules (25). The use of therapeutic herbs in developing 
countries as cures against leukemia is prominent. (7). Our findings showed 
selective toxicity of Mangifera Indica extract on cancerous B lymphocytes and 
their mitochondria obtained from CLL patients by MTT assay (Figure 1), while J. 
Regia extract didn’t show any significant toxicity on CLL lymphocytes and their 
mitochondria (Figure 1). The results indicate that Mangifera Indica is an excellent 
source of anti-cancerous agents and may prove fruitful herbal remedy in near 
future for help to CLL therapy. Also there are several studies on literatures that 
indicate Mangifera Indica extract and its isolated compounds have anticancer 
potential in many cancer cell lines (26, 27). Although in our studies we did not 
observe anticancer activity of J. Regia extract, nevertheless recent studies have 
shown J. Regia extract has anticancer activity (15, 28, 29). This difference may be 
due to the kind of species, cancer cell, the content, and interaction of active 
ingredient in the extract. 
The development of therapeutic strategies that target apoptosis in CLL is a very 
important issue (30). New targets such as mitochondria has facilitated the 
development of new drugs with a view to improving clinical outcomes for this 
neoplasm (31). So mitochondria are currently regarded as central organelles in 
mediating intrinsic death signals and might provide a novel target for new 
chemotherapeutics (32). Our results showed that Mangifera Indica extract could 
selectively induce apoptosis in CLL but not healthy normal B-lymphocytes and 
also showed that this selective apoptosis is initiated from mitochondria (Figure 2). 
The mitochondrial membrane permeability transition (MPT) is a serious step in 
induction of apoptosis (33). A mechanism causing the mitochondrial dysfunction is 
MPT which includes dissipation of the inner membrane potential, osmotic swelling 
of the matrix, rupture of the outer mitochondrial membrane, release of cytochrome 
c and other apoptogenic proteins, as well as formation of the caspase-3 activation 
complex in cytosol (34). In this study, we showed increased ROS formation after 
exposure to Mangifera Indica extract only in cancerous mitochondria but not 
normal mitochondria. The mitochondrial respiratory chain is one of the major 
sources of endogenous ROS (35). Several chemotherapeutic agents have been 
identified to promote mitochondrial ROS formation (36). ROS are responsible for 
induction of Ca
2
 dependent MPT (37, 38). MMP is a universal feature of cell death 
and is often considered as the “point of no return” in the cascade of the events 
leading to apoptosis (35, 39). Our results also revealed collapse mitochondria 
membrane potential (MMP) only on cancerous mitochondria confirming that MMP 
occurs after Mangifera Indica extract treatment on cancerous (Figure 5). Besides, 
addition of this extract to cancerous mitochondria also resulted in mitochondrial 
swelling (Figure 6). Several mechanisms for the release of Cyt c from 
mitochondria have so far been proposed, including dissociation of this peptide 
from the inner mitochondrial membrane in response to cardiolipin peroxidation by 
reactive oxygen species (ROS) (40). Several studies have proposed that the release 
of cytochrome c occurs due to the rupture of the mitochondrial outer membrane 
(41). In this study, we showed release of Cyt c only from cancerous but not normal 
mitochondria after treatment with Mangifera Indica extract. Moreover, Cs A and 
BHT pretreatment completely blocked the extract-induced release of cytochrome c 
from the cancerous mitochondria which supports the hypothesis that the apoptosis 
induction via Mangifera Indica extract is due to an oxidative stress and depends on 
the opening of the mitochondrial transition pores. 
Finally, our results suggest that Mangifera Indica can act promising source for 
anti-cancer drug candidate by directly and selectively targeting mitochondria in 
cancerous cells and thus could induce cell death through ROS mediated 
mitochondrial pathway which finally ends in cytochrome c release, caspase 3 
activation, and apoptosis in cancerous B-lymphocytes isolated from CLL patients. 
Hence, this extract may be a promising source in the future for the anti-cancer drug 
development in treatment of CLL. 
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